Beta Drugs Ltd

Stage 3 · Topping · week 2

Beta Drugs Limited develops, manufactures, and sells anti-cancer bulk drugs and finished dosages in India. More about the company

₹1,991.4
-0.50% today
₹2,019 Cr · Small cap
Market Neutral — FadingHealth Care 45.7% in Stage 2-1.4 pts / 20dPharmaceuticals 53.8%+3.8 pts
Loading price chart…
vs 52W High
-25.4%
₹1,030.3 lo₹2,668.3 hi
25.4% below 52W high — weakening from peak
Stock is rolling over from its 52W high. Stage 3 distribution — new longs are high risk here.
Stage Maturity
Week 2
1w13w26w
Week 2 — early distribution
How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.
vs 200 DMA
17.1%
200 DMA: ₹1,700.2 · rising
Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.
Rel Volume
0.31x
vs 50-day avg
Volume spikes on down days during Stage 3 signal distribution — institutions are exiting. A clear warning to avoid new longs.
Trend Health
↓
MA20 rolling over · -3.6% vs MA50 -2.9%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-10.2%
3M
-0.3%
6M
+48.2%
YTD
+26.2%
1Y
+10.4%
Sector
Health Care
↓ Peaking
Stage 2%
45.7%
20d Δ
-1.4pp
1M return
-1.8%
3M return
+4.4%
Sector Stage-2 % · last 20 days
Sector has 77 Stage 2 leaders. See Health Care Stage 2 →
Industry
Pharmaceuticals
↑ Building
Stage 2%
53.8%
20d Δ
+3.8pp
1M return
-0.9%
3M return
+3.6%
Industry Stage-2 % · last 20 days
Industry has 61 Stage 2 leaders. See Pharmaceuticals Stage 2 →
Stage Cycle Timeline2023-07-11 → 2026-10-07
S2 31w
S3 18w
S2 22w
S4 26w
2023-07-112026-10-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 2w → S3 1w → S2 31w → S3 18w → S4 4w → S1 3w → S2 22w → S3 12w → S4 3w → S1 5w → S4 10w → S1 5w → S2 5w → S3 1w → S4 26w → S1 7w → S2 12w → S3 1w current
Total tracked: 168 weeks across 18 stage runs.
Scan Membership
Prop Scan
Latest: 2026-08-25
Pullback Hunter
Latest: 2026-08-21
Breakout Watch
Latest: 2026-07-01
58 appearances in last 60 days. First seen: 2024-08-30.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-07S3
Wk 2 · Vol 0.31x
2026-10-06S3
Wk 2 · Vol 0.35x
2026-10-05S3
Wk 1 · Vol 0.67x
2026-10-01S3
Wk 1 · Vol 0.29x
2026-09-30S3
Wk 1 · Vol 0.23x
2026-09-29S3
Wk 1 · Vol 0.29x
2026-09-28S32→3
Wk 1 · Vol 0.31x
2026-09-25S2
Wk 13 · Vol 0.25x
2026-09-24S2
Wk 13 · Vol 0.38x
2026-09-23S2
Wk 12 · Vol 0.71x
2026-09-22S2
Wk 12 · Vol 0.48x
2026-09-21S2
Wk 12 · Vol 0.23x
Sector Peers — Stage 2All →
KOPRAN
wk 19 · -5.0% from hi
9.0
SMSPHARMA
wk 3 · -3.0% from hi
8.7
KILITCH
wk 2 · -1.7% from hi
8.7
BAFNAPH
wk 17 · 0.0% from hi
8.6
ZIMLAB
wk 21 · 0.0% from hi
8.3
Moving averages & range
50 DMA
₹2,229.2
200 DMA
₹1,700.2
52W High
₹2,668.3
52W Low
₹1,030.3
5D Low
₹1,991.4
Resistance levels (recent highs)
20d High
₹2,187.8
60d High
₹2,668.3
120d High
₹2,668.3
250d High
₹2,668.3
Next resistance
+9.9%
to 20d High
Ask the Market AI about BETAAsk →
P/E (TTM)
22.5
Forward —
Earnings Growth (YoY)
-5.0%
Revenue +0.2%
ROE
+18.8%
Profit margin +10.8%
About this companyHealth Care· Pharmaceuticals

Beta Drugs Limited develops, manufactures, and sells anti-cancer bulk drugs and finished dosages in India. The company offers cosmeceutical and oncology products. It also manufactures active pharmaceutical ingredients (API) and pharmaceutical formulation intermediates (PFI). The company exports its products. Beta Drugs Limited was founded in 1985 and is based in Panchkula, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.